[PDF][PDF] Varones al son de la migración. Migración internacional y masculinidades de Veracruz a Chicago
C Rosas - Política y Sociedad, 2011 - academia.edu
… Como nos dice la autora Carolina Rosas: “Estados Unidos brinda la posibilidad de cumplir
con muchas expectativas. Los logros son numerosos y cubren una amplia gama, que va …
con muchas expectativas. Los logros son numerosos y cubren una amplia gama, que va …
[BOOK][B] Implicaciones mutuas entre el género y la migración: varones y mujeres peruanos arribados a Buenos Aires entre 1990 y 2003
C Rosas - 2016 - books.google.com
Estas páginas presentan consideraciones acerca del carácter estructurante del sistema de
género, así como en las posibilidades de cambio social que se detonan luego del …
género, así como en las posibilidades de cambio social que se detonan luego del …
[HTML][HTML] Mother-to-child HTLV-1 transmission: unmet research needs
C Rosadas, GP Taylor - Frontiers in microbiology, 2019 - frontiersin.org
Mother-to-child transmission (MTCT) of Human T-cell lymphotropic virus type 1 (HTLV-1)
causes lifelong infection. At least 5–10 million individuals worldwide are currently living with …
causes lifelong infection. At least 5–10 million individuals worldwide are currently living with …
[HTML][HTML] Neurological complications in dengue infection: a review for clinical practice
M Puccioni-Sohler, C Rosadas… - Arquivos de neuro …, 2013 - SciELO Brasil
Dengue is an important global public health problem. The World Health Organization
estimates that 2/5 of entire world population are in risk of dengue infection. Almost 50 millions …
estimates that 2/5 of entire world population are in risk of dengue infection. Almost 50 millions …
[HTML][HTML] HTLV-1 and co-infections
C Rosadas, GP Taylor - Frontiers in Medicine, 2022 - frontiersin.org
HTLV-1 is a retrovirus that causes lifelong T-cell infection in humans, impacting the host
immune response. This virus causes a range of clinical manifestations, from inflammatory …
immune response. This virus causes a range of clinical manifestations, from inflammatory …
[HTML][HTML] Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts
…, J Cutajar, RS Thwaites, E Parker, C Rosadas… - Nature …, 2022 - nature.com
Cross-reactive immune responses to SARS-CoV-2 have been observed in pre-pandemic
cohorts and proposed to contribute to host protection. Here we assess 52 COVID-19 …
cohorts and proposed to contribute to host protection. Here we assess 52 COVID-19 …
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity
…, C Rees-Spear, E Parker, MS Dos Santos, C Rosadas… - SciAdv, 2021 - science.org
The coronaviral spike is the dominant viral antigen and the target of neutralizing antibodies.
We show that SARS-CoV-2 spike binds biliverdin and bilirubin, the tetrapyrrole products of …
We show that SARS-CoV-2 spike binds biliverdin and bilirubin, the tetrapyrrole products of …
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey
…, L Naar, R Klaber, A Badhan, C Rosadas… - Thorax, 2020 - thorax.bmj.com
Background Accurate antibody tests are essential to monitor the SARS-CoV-2 pandemic.
Lateral flow immunoassays (LFIAs) can deliver testing at scale. However, reported …
Lateral flow immunoassays (LFIAs) can deliver testing at scale. However, reported …
[HTML][HTML] Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort study
…, MR Tolosa-Wright, L Mosscrop, C Rosadas… - The Lancet …, 2023 - thelancet.com
Background Despite circumstantial evidence for aerosol and fomite spread of SARS-CoV-2,
empirical data linking either pathway with transmission are scarce. Here we aimed to assess …
empirical data linking either pathway with transmission are scarce. Here we aimed to assess …
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study
…, L Naar, R Klaber, A Badhan, C Rosadas… - bmj, 2021 - bmj.com
Objective To evaluate the performance of new lateral flow immunoassays (LFIAs) suitable
for use in a national coronavirus disease 2019 (covid-19) seroprevalence programme (real …
for use in a national coronavirus disease 2019 (covid-19) seroprevalence programme (real …